Artur Widak/NurPhoto via Getty Images

A Very Simple Way to Get America Boosted

Nudging people toward third shots with financial incentives may be one of the lowest-hanging fruits in pandemic policy making.

Unfortunately, Omicron is far from done with us. More than 700,000 Americans are testing positive for COVID-19 every day, COVID hospitalizations in the United States are at a record high, and the variant is so contagious that an encounter with it can be postponed for only so long. The single best thing people can do to protect themselves is, yes, get vaccinated. And that includes booster shots.

The immunity boost of that third shot is something of a game changer: CDC data have shown that booster shots significantly ratchet up protection from Omicron hospitalization, compared with two vaccine doses. In some charts of COVID deaths and hospitalizations, the number of triple-jabbed patients is so low, you have to squint to find them in the graphs. And though it’s not clear how long this extra protection will last, what makes getting boosted now even more of a no-brainer is that the added protection starts to build in just a few days—far quicker than after the first shot—meaning that even this long into the Omicron wave, third shots can help stave off COVID’s worst outcomes, as well as immunologically arm us for whatever variant comes next.

And yet the rate of Americans who have received a booster shot is abysmally low. Although 87 percent of adults have received one vaccine dose, just 52 percent of eligible vaccinated adults are boosted—less than a third of the total adult population. One thing that could help is booster mandates—sticks over carrots. Mandates may be controversial, but they are effective. Even so, at least so far, we’ve seen astonishingly few companies or governments roll out booster mandates. Don’t expect many more: Last week, the Supreme Court batted down an effort by the Biden administration to mandate vaccines for large employers. Some companies, such as Starbucks, have responded by nixing the mandates they had voluntarily implemented.

[Read: Fully vaccinated is about to mean something else]

So what about carrots? During the initial vaccine rollout, incentives were hot: Two dozen states were sweetening the immunization pot with million-dollar lotteries, a chance to drive your car on the Talladega Superspeedway, TikTok contests for $250 gift cards, tickets to baseball games, $100,000 scholarships, hunting and fishing licenses, a pontoon boat, a free beer at a local brewery, or just $100 to spend however you wanted. But even as booster shots could help lessen the burden of Omicron and future variants, governments have largely abandoned these ambitious incentive programs. I reached out to the 24 states that offered incentives last year, and of the 15 that responded, 13 aren’t offering financial incentives for boosters. Arkansas still hands out a $20 lottery ticket to anyone who gets a shot—including a booster—while New York is offering the unboosted a chance to win free ski passes.

This complacency around booster incentives is especially baffling because after a summer of lotteries and sweepstakes, we have a better sense of which programs show promise and which definitely don’t work. Incentive programs are never going to be the cohesive national strategy that gets us out of the pandemic. But they probably do still have a role to play: Unlike people who are staunchly opposed to vaccines, most of the unboosted are by definition not opposed to vaccines. Nudging them toward a third shot may be one of the lowest-hanging fruits in pandemic policy making.


Slipping someone a $100 bill might seem like a roundabout way for a country to induce its residents to accept a lifesaving vaccine, but last year officials were desperate to get shots into arms. Politicians of all stripes flocked to incentive programs because they appeal to both sides of the political spectrum. On the right, incentives align with free-market ideologies that place choice in the hands of individuals. On the left, incentives are alluring because they may alleviate equity issues by removing financial barriers for low-income populations.

Theoretically, incentives should work. Offering people cash to change health behaviors—whether to quit smoking or keep up with exercise—made a difference in previous studies. Cash might provide a fence-sitter justification to get vaccinated, or it might offer cover for someone whose desire for a vaccine goes against local social norms. And even though the COVID vaccines are free, they come with indirect costs, such as lost wages when taking time off from work to get a shot.

[Read: Vaccine lottery tickets are sad, but also perfect]

But theory is different from practice. “It was completely unprecedented for 24 states, more or less at the same time, to roll out these incentive programs,” says Kevin Volpp, the founding director of the Center for Health Incentives and Behavioral Economics at the University of Pennsylvania. In effect, it was a grand national experiment in whether financial incentives such as lotteries and cash guarantees work, so Volpp and his colleagues decided to put the numbers through the wringer. Despite the millions of dollars poured into these high-profile efforts, they found no difference in vaccination patterns between the 24 states with incentives and the 26 states without them.

Their study wasn’t an anomaly. Although the lotteries and cash giveaways generated much fanfare, and governors boasted of their effectiveness, a flurry of academic studies now suggests that most large-scale financial-incentive programs had minimal impact, or were total duds. It’s not clear why the incentive programs seemed to fail, but Mireille Jacobson and Tom Chang, two economists at the University of Southern California, have some suspicions.

Over the summer, they recruited 2,700 participants and randomly divided them into several groups—some were offered up to $50 in cash to get vaccinated, while others viewed public-health messages or received scheduling links that would make finding an appointment easier. The study itself took two months, but the analysis was basically ready in hours. “We could tell pretty quickly that there was no there there,” Chang told me. They found that for Donald Trump voters, the guaranteed $50 financial incentive actually decreased vaccination rates. “It’s not normal to pay someone to do something that’s good for them,” Chang said. If a vaccine is so good, the thinking goes, “then why do you have to pay people to take it?”


But that’s not to say we should give up on incentives altogether—especially now that the future of mandates seems shakier than ever. Even though statewide lotteries and beer giveaways proved to be gimmicky busts, there could still be a role for better-designed incentive programs, especially those that target specific populations. Unboosted Americans are disproportionately racial minoritiesmembers of low-income families, and undocumented immigrants—the same populations that are most likely to be exposed to the virus and miss work because of COVID. For them, the chance to win millions in a lottery does nothing if they can’t physically get themselves to a vaccination clinic or take time off work. Booster incentives might be more successful if they were deployed in a way that acknowledges the complexity of human psychology, local social context, and structural barriers.

Sandrette Parker, a 47-year-old mother of three who lives in Henderson, North Carolina, told me that she faced these barriers. After a few months of hesitation, she finally decided that it was time to get her first shot. But there was a problem: She couldn’t get to a clinic. After losing her job, she said, “My choices were to pay rent, or pay my car payment.” Life without a car was tricky. “There’s no public transportation here, no city buses, and I don’t think I’ve ever seen a taxicab in this town,” she said. Parker finally found someone to take her family to the closest open vaccination site, some 50 miles away. A few months later, Parker said, she and her family tested positive for COVID. “Thankfully, we all had become fully vaccinated prior to catching COVID because I think it would have been worse.”

To address logistical issues like Parker’s, Charlene Wong, the chief health-policy officer for COVID-19 at the North Carolina Department of Health and Human Services, designed a clever incentive program during the late spring. Her team offered people in undervaccinated counties $25 cash cards to get vaccinated—but it also added a twist, what Wong calls a “social incentive.” Anyone who drove someone else to receive a first dose also received a $25 cash card. “Social incentives really leverage the fact that we have networks of folks around us to influence our behaviors,” Wong said. The design worked: Vaccination rates were decreasing nearly everywhere in the country by that time, and the program slowed the decline by half at clinics with incentives compared with neighboring clinics without incentives. With boosters, “those same barriers—transportation, lost wages, child care—they aren’t going to magically disappear,” Wong said.

[Read: It’s a terrible idea to deny medical care to unvaccinated people]

What Wong’s study suggests is that simple quid pro quo financial incentives may not be sufficient to make vaccine access equitable. Julia Raifman, a public-health professor at Boston University, told me that “making vaccines easy to access—for example, a walk-in clinic, well advertised and nearby—and broad communications about who was at risk are likely more important than the financial incentives.” Community organizations around the country are racing to figure out what works. La Colaborativa, a Boston-area community organization, successfully increased vaccination rates in the low-income suburb of Chelsea to 92 percent by offering vaccination sign-ups at the same location people could pick up a box of free food or access social services. Our Healthy KC Eastside lifted vaccination rates in some of Kansas City, Missouri’s predominantly Black neighborhoods by 50 percent compared with the citywide average–by putting clinics in convenient locations and giving out $50 for first shots.


There’s been no systematic assessment of how effective these more targeted programs have been nationwide. But even without the sort of high-quality evidence we would want, there’s a moral argument that anyone who wants a life-saving vaccine should be able to access it–particularly those from communities that could gain the most from third shots. From a strictly economic perspective, pouring money into booster incentives is a bet, but perhaps one worth taking. No matter what happens with workplace mandates going forward, millions of people, including the unemployed and retirees, won’t be covered by them. Targeting these people will cost money, but so will leaving people less protected from COVID.

I asked Chang and Jacobson what they would say if the governor of California, for example, called them up tomorrow to inquire about a statewide incentive program for 2022. They both agreed that it would be pointless for first doses. “I’d say do it for boosters, though,” Chang said. Jacobson concurred. “I think there are a lot of people who are in this camp of Yeah, I’m gonna get a booster but I’m not in any rush,” she said. “And I would think those folks are probably pretty responsive” to financial incentives.

After all, the whole point of nudges is that you target someone who’s kind of indifferent, and for whom a small incentive slightly lowers the burden of time, effort, or actual financial cost. For incentives to work, you need a lot of people on the fence—which is exactly the place we’re in with boosters. And yet there’s no longer the spirit of experimentation that pervaded the initial vaccine rollout, or really, it seems, much of a plan at all. We now know that dumping money into big-ticket lotteries maybe isn’t the best idea. And sure, maybe incentives aren’t the answer at all. But compared with the economic and human costs of not getting Americans boosted, is the small probability of landing a free ski pass really the best we can do?

This article was originally published in The Atlantic. Sign up for their newsletter

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.